RNU11-2P

Across TCGA pan-cancer cohorts, RNU11-2P RNA is linked to patient survival in 11 of 34 cancer types, making it the most broadly survival-associated RNU11-2P data layer.

The strongest signal is observed in bladder urothelial carcinoma (BLCA), where higher RNU11-2P RNA is associated with better overall survival. In most high-consensus cancer types, elevated RNU11-2P expression acts as an unfavorable survival marker, although some lineages such as BLCA and LAML show a favorable association.

BLCA, LUSC, and UVM are the cancer types where RNU11-2P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
BLCA	OS	Tertile	All	1.000	0.534	.004	105	view →
LUSC	OS	Tertile	IV	0.001	0.673	.014	39	view →
UVM	OS	Tertile	All	0.218	0.696	.014	36	view →
LIHC	OS	Tertile	III,IV	0.079	0.737	.004	36	view →
LAML	DFS	Quartile	All	0.703	0.447	.011	30	view →
LGG	OS	Tertile	All	0.730	0.401	.001	21	view →
SKCM	DFS	Tertile	II,III,IV	0.404	0.728	.003	18	view →
LUAD	DFS	Tertile	IV	0.333	0.671	.048	18	view →
READ	DFS	Tertile	II,III,IV	0.206	0.723	.006	18	view →
OV	OS	Quartile	III,IV	0.752	0.860	.001	18	view →
CESC	DFS	Tertile	All	0.803	0.496	.036	12	view →

Pink = unfavorable, green = favorable. Showing the 11 strongest of 11 lineages.

RNU11-2P–BLCA (OS)

Open the BLCA breakdown →